EDITOR: | October 9th, 2018

GCAC signs LOI with California Partner for use of the Citizen Green Patient-Care Solution for Medical Cannabis

| October 09, 2018 | No Comments

October 9, 2018 (Source) — Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP), (FSE: 2FA), (OTCQB: FUAPF), a leading developer of innovative data technologies for the medical cannabis industry, is pleased to announce it has signed a letter of intent (the “LOI”) with Cannact LLC (“Cannact”), a seasoned distributor of cannabis technology and products in California, to enter into a license agreement to integrate the Citizen Green patient-care solution onto Cannact’s platform with potential integration for related cannabis retailer partners.

“We are very impressed with the Citizen Green Community platform, its technology solution and crypto-based loyalty program offered through a partnership with CGAC,” said Yoni Alter, co-founder and Chief Operations Officer at Cannact LLC. “Our goal is to ensure our customers are receiving the very best in customer care and that their experience with cannabis has a positive impact on physical and mental health. Having a resource like the Citizen Green Prescriptii patient-care solution for us and our customers will enable an improved and more complete medical cannabis treatment.”

Said Brad Moore, CEO of GCAC “Cannact is the first of many licensed producers and dispensaries who will seek Citizen Green’s innovated solutions to improve health, safety and patient outcomes in the cannabis industry. Our Onward Program is a cutting-edge, one-of-a-kind loyalty reward program using the Citizen Green Coin cryptocurrency as an incentive tool to acquire new customers and retain existing ones. I look forward to working with the Cannact team as we integrate our innovative solution for the medical cannabis industry.”

The Cannact team have established relationships with over 50 (fifty) retail partners and dispensaries. The Citizen Green Prescriptii solution will be integrated onto the Cannact platform and then offered to its large retail, distribution and medical partner network. This will provide the basis for the GCAC and Cannact to collaborate and collect clinical and user cannabis data with the goal of validating treatment efficacy and improving patient outcomes globally.

Citizen Green’s Prescripitii solution is an innovative patient care application that builds and enhances the relationship of trust that already exists between medical cannabis sellers and their patients. The use of smart technology to drive better health outcomes enables licensed producers, retail owners, dispensaries and pharmacies to focus on their business’s success. The Prescriptii desktop application offers the best possible medical cannabis product for a specific ailment for clients, which are tracked and recorded to include usage experiences. This information is aggregated and then made available to the retailer enabling them to better understand their clients and provide superior guidance on next steps.

GCAC has launched its innovative Citizen Green patient-care solution to the global cannabis marketplace, starting with California which is experiencing explosive growth.

About Cannact LLC

Cannact LLC is a distributor of cannabis products and technologies, based out of Sacramento, California. With years of experience in the California market, the Cannact team has established relationships with every phase of the supply chain. From the cultivator to the manufacturer, distributor, and retailer, Cannact have built a platform for distribution of unique cannabis technologies throughout California.

About Global Cannabis Applications Corp.

Global Cannabis Applications Corp. is a global leader in designing, developing, marketing and acquiring innovative data technologies for the medical cannabis industry. The Citizen Green platform is the world’s first end-to-end – from patient to regulator – medical cannabis data solution. It uses six core technologies: mobile applications, artificial intelligence, regtech, smart databases, blockchain and digital reward cyrptocurrency, to qualify candidates for clinical studies. These technologies facilitate the proliferation of digital conversations by like-minded people in the medical cannabis community. Managed by digital and cannabis industry experts, GCAC is focused on viral global expansion by providing the best digital experience in the cannabis market.

For more information about the Company, please visit online at www.cannappscorp.com, or review its profiles www.sedar.com and on the Canadian Securities Exchange’s website (www.thecse.com).

Forward-Looking Information

This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.



InvestorIntel.com is a leading online source of investor information that provides public market coverage for both investors and industry alike. A qualified online influencer through ... <Read more about InvestorIntel>

Copyright © 2020 InvestorIntel Corp. All rights reserved. More & Disclaimer »

Leave a Reply

Your email address will not be published. Required fields are marked *